Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07454408) titled 'Evaluation of the Outcome of Fecal Microbiota Transplantation' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
Primary Sponsor: Air Force Military Medical University, China
Condition:
Hepatic Encephalopathy
Fecal Microbiota Transplantation
TIPS
Intervention:
Biological: Fecal Microbiota Transplantation
Other: FMT Matched Placebo
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: March 7, 2026
Target Sample Size: 40
Countries of...